Pancreatitis - Microbiome As Predictor of Severity

NCT04777812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 424

Last updated 2024-04-30

No results posted yet for this study

Summary

This study is a multicentric prospective study initiated and coordinated from the University Medical Centre Goettingen. The study aims to evaluate the orointestinal microbiome as a potential biomarker for the course, severity and outcome of patients with acute pancreatitis.

Conditions

Interventions

DIAGNOSTIC_TEST

Rectal and buccal swabs

The oral and intestinal flora is collected from buccal and rectal swabs.

Sponsors & Collaborators

  • Department of Medicine II, University Hospital Rostock

    collaborator UNKNOWN
  • Medical Department II, Division of Gastroenterology, University Hospital of Leipzig

    collaborator UNKNOWN
  • Department of Medicine II, University Hospital, LMU Munich

    collaborator UNKNOWN
  • Department of Medicine I, University Hospital of Halle

    collaborator UNKNOWN
  • Department of Medicine A, University Medicine Greifswald

    collaborator UNKNOWN
  • Department of Medicine II, University Hospital rechts der Isar, Technical University Munich

    collaborator UNKNOWN
  • Department of Medical Bioinformatics, University Medical Center Göttingen

    collaborator UNKNOWN
  • Department if Medical Statistics, University Medical Center Göttingen

    collaborator UNKNOWN
  • University Medical Center Goettingen

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-17
Primary Completion
2023-09-30
Completion
2024-02-23

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04777812 on ClinicalTrials.gov